JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265518

Human RYK knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

RYK KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 160 bp deletion in exon 2 and 1 bp deletion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human RYK knockout HeLa cell line (AB265518)
  • Sanger seq

Unknown

Sanger Sequencing - Human RYK knockout HeLa cell line (AB265518)

Allele-1 : 1 bp deletion in exon 2.

Sanger Sequencing - Human RYK knockout HeLa cell line (AB265518)
  • Sanger seq

Unknown

Sanger Sequencing - Human RYK knockout HeLa cell line (AB265518)

Allele-2 : 160 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 160 bp deletion in exon 2 and 1 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265518-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265518-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265518 Human RYK knockout HeLa cell line", "number":"AB265518-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265518-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265518 Human RYK knockout HeLa cell line", "number":"AB265518-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265518-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265518-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265518 Human RYK knockout HeLa cell line", "number":"AB265518-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265518-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265518 Human RYK knockout HeLa cell line", "number":"AB265518-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
RYK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The receptor-like tyrosine kinase (RYK) also known as RYK receptor-like tyrosine kinase is a protein involved in Wnt signaling pathways. It has a molecular mass of approximately 74 kDa. RYK functions as a single-pass type I membrane protein and primarily acts as a receptor for Wnt proteins. It is expressed in various tissues including brain testis and pancreas reflecting its diverse roles in developmental and physiological processes.
Biological function summary

RYK modulates cellular communication by interacting with Wnt proteins. It does not possess intrinsic kinase activity but participates in signaling as part of a larger receptor complex on the cell surface. This complex includes other proteins such as Frizzled receptors and LRP co-receptors facilitating the translation of extracellular Wnt signals into intracellular responses. RYK although not a conventional kinase plays a pivotal role in neuronal development influencing axon guidance and synaptic formation.

Pathways

RYK is integral to the Wnt signaling pathway which is essential for cell proliferation differentiation and migration. Through the Wnt pathway RYK interacts with other proteins such as Disheveled (Dvl) to execute its signaling functions. Additionally RYK has associations with the non-canonical Wnt/PCP (planar cell polarity) pathway modulating tissue polarity and cell movement during embryogenesis. Its role within these pathways highlights the intricate regulatory networks involved in developmental biology.

RYK has associations with cancer and neurodevelopmental disorders. Aberrant expression or mutations in RYK can contribute to tumor growth and metastasis implicating it in cancers such as glioma. During neurodevelopment alterations in RYK signaling can lead to disorders like autism spectrum disorder (ASD). RYK interacts with proteins such as β-catenin in pathological states influencing the progression of these conditions. Understanding RYK's involvement in these diseases provides insights that could facilitate therapeutic strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com